Filing Details
- Accession Number:
- 0001562180-18-004643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-21 16:26:08
- Reporting Period:
- 2018-11-19
- Accepted Time:
- 2018-11-21 16:26:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590877 | Regenxbio Inc. | RGNX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1192128 | M Luke Beshar | C/O Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-19 | 2,604 | $49.45 | 2,604 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-19 | 6,250 | $18.85 | 8,854 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-19 | 3,262 | $12.74 | 12,116 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-19 | 10,916 | $60.26 | 1,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-19 | 600 | $62.81 | 600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-19 | 600 | $63.53 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 4,688 | $22.00 | 4,688 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 2,988 | $12.74 | 7,676 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 13,500 | $3.76 | 21,176 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-20 | 21,176 | $60.38 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-11-19 | 2,604 | $0.00 | 2,604 | $49.45 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-11-19 | 6,250 | $0.00 | 6,250 | $18.85 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-11-19 | 3,262 | $0.00 | 3,262 | $12.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-11-20 | 4,688 | $0.00 | 4,688 | $22.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-11-20 | 2,988 | $0.00 | 2,988 | $12.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-11-20 | 13,500 | $0.00 | 13,500 | $3.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,896 | 2028-05-25 | No | 4 | M | Direct | |
| 6,250 | 2027-05-24 | No | 4 | M | Direct | |
| 9,238 | 2026-06-01 | No | 4 | M | Direct | |
| 4,687 | 2025-09-16 | No | 4 | M | Direct | |
| 6,250 | 2026-06-01 | No | 4 | M | Direct | |
| 66,500 | 2025-05-18 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- The previously granted option, representing a right to purchase a total of 80,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter.
- This transaction was executed in multiple trades at prices ranging from $60.00 to $60.685. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $62.06 to $63.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $63.34 to $64.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $60.00 to $60.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vests in 12 equal monthly installments following May 25, 2018.
- The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following May 24, 2017.
- The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016.
- The previously granted option, representing a right to purchase a total of 9,375 shares, became exercisable as follows: the option vested in nine equal monthly installments following September 16, 2015.
Billionaire Hedge Funds
